Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c.547G>A

Leukemia

Volumn 28, Issue 5, 2014, Pages 1136-1138

  Auer, F ^a   Ruschendorf F ^b   Gombert, M ^a   Husemann, P ^a,c   Ginzel, S ^a,d   Izraeli, S ^e,f   Harit, M ^g   Weintraub, M ^g   Weinstein, O Y ^g   Lerer, I ^g   Stepensky, P ^g   Borkhardt, A ^a   Hauer, J ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d Department of Computer Science Bonn Rhine Sieg University of Applied Sciences ^*  (Germany)

^e SHEBA MEDICAL CENTER   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

^g HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; TRANSCRIPTION FACTOR PAX5;

ACUTE LYMPHOBLASTIC LEUKEMIA; AUTOSOMAL DOMINANT INHERITANCE; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME ABERRATION; COPY NUMBER VARIATION; FAMILIAL CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC ANALYSIS; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERMLINE MUTATION; HAPLOTYPE; HETEROZYGOSITY LOSS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LETTER; LEUKEMIA CELL; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 84899934875     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.363     Document Type: Letter

References (6)

1. Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C. et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet 2013; 45: 1226-1231.
2. Sherborne AL, Hosking FJ, Prasad RB, Kumar R, Koehler R, Vijayakrishnan J. et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet 2010; 42: 492-494.
3. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E. et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1006-1010.
4. Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil E, Koehler R, Greaves M. et al. Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood. Blood 2010; 115: 1765-1767.
5. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M. et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet 2009; 41: 1001-1005.
6. Chen C, Bartenhagen C, Gombert M, Okpanyi V, Binder V, Rottgers S. et al. Next-generation-sequencing-based risk stratification and identification of new genes involved in structural and sequence variations in near haploid lymphoblastic leukemia. Genes Chromosomes Cancer 2013; 52: 564-579.